Waystar Weighs Sale as Market Value Dips Amid Software Sector Slump
Waystar is exploring strategic options, including a sale, following a significant drop in its market value this year.
Waystar, a healthcare software provider specializing in automating administrative tasks for hospitals and doctors, is exploring strategic options, including a potential sale, according to sources familiar with the matter. The company, which went public in New York two years ago, has seen its market value decrease to approximately $4.8 billion following a 24% decline in share price this year.
The Lehi, Utah, and Louisville, Kentucky-based firm has engaged investment bank Evercore to advise on the process, which is reportedly in its early stages. Sources indicate that while a sale is being considered, plans are not yet finalized and the outcome remains uncertain. Both Waystar and Evercore have declined to comment on the matter.
Market Challenges and Strategic Positioning
Waystar's decision to explore a sale comes amid broader uncertainties in the software sector, with investors expressing concerns over potential disruptions due to advances in artificial intelligence. Initially, Waystar positioned itself as a technology company to capitalize on higher valuations compared to traditional healthcare services businesses. This approach initially proved successful, with share prices rising from $20 to a peak of $45 in 2025.
However, recent market conditions have reversed some of these gains. Analysts at Morgan Stanley, in a July report, noted that investor sentiment has shifted, impacting software companies' market performance.
Corporate Background and Ownership
Waystar was formed in 2017 through the merger of healthcare revenue management firms Zirmed and Navicure. It was taken public in 2024 by its major stakeholders, including EQT, the Canada Pension Plan Investment Board (CPPIB), and Bain Capital. EQT remains the largest shareholder with a 13% stake, followed by CPPIB at 10% and BlackRock Institutional Trust Company holding 8%, according to data from LSEG.
As the company navigates these strategic considerations, its potential sale could signal investor interest in the software sector's resilience despite current market challenges. The auction process may provide insights into whether investor appetite is rebounding.
Neither EQT nor BlackRock have commented on the potential sale, and CPPIB has not responded to requests for comment.